ReviewDrug design, development and therapy2016

Three generations of epidermal growth factor receptor tyrosine kinase inhibitors developed to revolutionize the therapy of lung cancer.

Haijun ZhangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.